Clinical Trial Update: Reprometabolic Syndrome Mediates Subfertility in Obesity [NA]

View source ↗

Summary

This clinical trial update discusses reprometabolic syndrome as a mediator of subfertility in obesity. The trial's results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinemia
• Hypogonadotropic Hypogonadism
• Infertility
• Obesity

Snippet

Sponsor: University of Colorado, Denver | Conditions: Obesity, Infertility | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-06-01